Final results of the HEALING IIB trial to evaluate a bio-engineered CD34 antibody coated stent (Genous™Stent) designed to promote vascular healing by capture of circulating endothelial progenitor cells in CAD patients

Atherosclerosis

Volumn 219, Issue 1, 2011, Pages 245-252

  den Dekker, Wijnand K ^a   Houtgraaf, Jaco H ^a   Onuma, Yoshinobu ^a   Benit, Edouard ^b   de Winter, Robbert J ^c   Wijns, William ^d   Grisold, Manfred ^e   Verheye, Stephan ^f   Silber, Sigmund ^g   Teiger, Emmanuel ^h   Rowland, Stephen M ⁱ   Ligtenberg, Erik ⁱ   Hill, Jonathan ^j   Wiemer, Marcus ^k   den Heijer, Peter ^l   Rensing, Benno J ^m   Channon, Keith M ⁿ   Serruys, Patrick W J C ^a   Duckers, Henricus J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b VIRGA JESSE HOSPITAL   (Belgium)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d Onze Lieve Vrouwe Gasthuis   (Belgium)

^e UNIVERSITY HOSPITAL GRAZ   (Austria)

^f MIDDELHEIM HOSPITAL   (Belgium)

^g Kardiologische Praxis in der Klinik   (Germany)

^h HENRI MONDOR HOSPITAL   (France)

ⁱ OrbusNeich   (United States)

^j KING S COLLEGE HOSPITAL   (United Kingdom)

^k RUHR UNIVERSITY BOCHUM   (Germany)

^l AMPHIA HOSPITAL   (Netherlands)

^m ST ANTONIUS HOSPITAL   (Netherlands)

ⁿ JOHN RADCLIFFE HOSPITAL   (United Kingdom)

more..

Author keywords

Arterial healing; Endothelial progenitor cell; Neo intima hyperplasia; Re endothelialization; Restenosis; Stent

Indexed keywords

ATORVASTATIN; CD34 ANTIBODY;

ADULT; AGED; ARTICLE; CORONARY ARTERY DISEASE; CORONARY STENT; DEATH; DEVICE SAFETY; DRUG ELUTING STENT; ENDOTHELIAL PROGENITOR CELL; FEMALE; FOLLOW UP; HEART MUSCLE REVASCULARIZATION; HUMAN; IN-STENT RESTENOSIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OPEN STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESTENOSIS; REVASCULARIZATION; STENT THROMBOSIS; THERAPY EFFECT; TREATMENT OUTCOME;

ADULT; AGED; ANTIGENS, CD34; CELL MOVEMENT; COATED MATERIALS, BIOCOMPATIBLE; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; DISEASE-FREE SURVIVAL; DRUG-ELUTING STENTS; ENDOTHELIAL CELLS; FEMALE; FOLLOW-UP STUDIES; HEPTANOIC ACIDS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PYRROLES; STEM CELLS; STENTS; TREATMENT OUTCOME;

EID: 80054968919     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.06.032     Document Type: Article

References (30)

1. Serruys P.W., Morice M.C., Kappetein A.P., et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 2009, 360:961-972.
2. Nakazawa G., Finn A.V., Joner M., et al. Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study. Circulation 2008, 118:1138-1145.
3. Hofma S.H., van der Giessen W.J., van Dalen B.M., et al. Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation. Eur Heart J 2006, 27:166-170.
4. Walter D.H., Cejna M., Diaz-Sandoval L., et al. Local gene transfer of phVEGF-2 plasmid by gene-eluting stents: an alternative strategy for inhibition of restenosis. Circulation 2004, 110:36-45.
5. Nakazawa G., Granada J.F., Alviar C.L., et al. Anti-CD34 antibodies immobilized on the surface of sirolimus-eluting stents enhance stent endothelialization. JACC Cardiovasc Interv 2011, 3:68-75.
6. Aoki J., Serruys P.W., van Beusekom H., et al. Endothelial progenitor cell capture by stents coated with antibody against CD34: the HEALING-FIM (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth-First In Man) Registry. J Am Coll Cardiol 2005, 45:1574-1579.
7. Duckers H.J., Silber S., de Winter R., et al. Circulating endothelial progenitor cells predict angiographic and intravascular ultrasound outcome following percutaneous coronary interventions in the HEALING-II trial: evaluation of an endothelial progenitor cell capturing stent. EuroIntervention 2007, 3:67-75.
8. Duckers H.J., Soullie T., den Heijer P., et al. Accelerated vascular repair following percutaneous coronary intervention by capture of endothelial progenitor cells promotes regression of neointimal growth at long term follow-up: final results of the Healing II trial using an endothelial progenitor cell capturing stent (Genous R stent). EuroIntervention 2007, 3:350-358.
9. Vasa M., Fichtlscherer S., Aicher A., et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001, 89:E1-E7.
10. Dimmeler S., Aicher A., Vasa M., et al. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest 2001, 108:391-397.
11. Spyridopoulos I., Haendeler J., Urbich C., et al. Statins enhance migratory capacity by upregulation of the telomere repeat-binding factor TRF2 in endothelial progenitor cells. Circulation 2004, 110:3136-3142.
12. Aoki J., Abizaid A.C., Serruys P.W., et al. Evaluation of four-year coronary artery response after sirolimus-eluting stent implantation using serial quantitative intravascular ultrasound and computer-assisted grayscale value analysis for plaque composition in event-free patients. J Am Coll Cardiol 2005, 46:1670-1676.
13. Reidy M.A., Silver M. Endothelial regeneration. VII. Lack of intimal proliferation after defined injury to rat aorta. Am J Pathol 1985, 118:173-177.
14. Fingerle J., Au Y.P., Clowes A.W., Reidy M.A. Intimal lesion formation in rat carotid arteries after endothelial denudation in absence of medial injury. Arteriosclerosis 1990, 10:1082-1087.
15. Conte M.S., Choudhury R.P., Shirakowa M., Fallon J.T., Birinyi L.K., Choudhry R.P. Endothelial cell seeding fails to attenuate intimal thickening in balloon-injured rabbit arteries. J Vasc Surg 1995, 21:413-421.
16. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993, 362:801-809.
17. Anderson P.G., Bajaj R.K., Baxley W.A., Roubin G.S. Vascular pathology of balloon-expandable flexible coil stents in humans. J Am Coll Cardiol 1992, 19:372-381.
18. Van Belle E., Maillard L., Tio F.O., Isner J.M. Accelerated endothelialization by local delivery of recombinant human vascular endothelial growth factor reduces in-stent intimal formation. Biochem Biophys Res Commun 1997, 235:311-316.
19. Rauscher F.M., Goldschmidt-Clermont P.J., Davis B.H., et al. Aging, progenitor cell exhaustion, and atherosclerosis. Circulation 2003, 108:457-463.
20. George J., Herz I., Goldstein E., Abashidze S., Deutch V., Finkelstein A., et al. Number and adhesive properties of circulating endothelial progenitor cells in patients with in-stent restenosis. Arterioscler Thromb Vasc Biol 2003, 23:e57-e60.
21. Blindt R., Vogt F., Astafieva I., et al. A novel drug-eluting stent coated with an integrin-binding cyclic Arg-Gly-Asp peptide inhibits neointimal hyperplasia by recruiting endothelial progenitor cells. J Am Coll Cardiol 2006, 47:1786-1795.
22. George J., Afek A., Abashidze A., et al. Transfer of endothelial progenitor and bone marrow cells influences atherosclerotic plaque size and composition in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol 2005, 25:2636-2641.
23. Granada J.F., Inami S., Aboodi M.S., et al. evelopment of a novel prohealing stent designed to deliver sirolimus from a biodegradable abluminal matrix. Circ Cardiovasc Interv 2010, 3:257-266.
24. Rotmans J.I., Heyligers J.M., Verhagen H.J., et al. In vivo cell seeding with anti-CD34 antibodies successfully accelerates endothelialization but stimulates intimal hyperplasia in porcine arteriovenous expanded polytetrafluoroethylene grafts. Circulation 2005, 112:12-18.
25. Larsen K, Cheng C, Tempel D, et al. Capture of circulatory endothelial progenitor cells and accelerated re-endothelialization of a bio-engineered stent in human ex-vivo shunt and rabbit model. Eur Heart J, in press.
26. Groves H.M., Kinlough-Rathbone R.L., Richardson M., Moore S., Mustard J.F. Platelet interaction with damaged rabbit aorta. Lab Invest 1979, 40:194-200.
27. Clowes A.W., Clowes M.M., Reidy M.A. Kinetics of cellular proliferation after arterial injury. III. Endothelial and smooth muscle growth in chronically denuded vessels. Lab Invest 1986, 54:295-303.
28. Van Belle E., Tio F.O., Couffinhal T., Maillard L., Passeri J., Isner J.M. Stent endothelialization, time course, impact of local catheter delivery, feasibility of recombinant protein administration, and response to cytokine expedition. Circulation 1997, 95:438-448.
29. Nakazawa G., Ladich E., Finn A.V., Virmani R. Pathophysiology of vascular healing and stent mediated arterial injury. EuroIntervention 2008, 4(Suppl. C):C7-C10.
30. Silber S., Damman P., Klomp M., et al. Clinical results after coronary stenting with the Genous Bio-engineered R stent: 12-month outcomes of the e-HEALING (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth) worldwide registry. EuroIntervention 2011, 6:819-825.